Stay updated on Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.

Latest updates to the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page
- Check5 days agoChange DetectedTaoyuan District, Taiwan, 333 was replaced with Taoyuan, Taiwan, 333 in the locations list, updating the site entry to reflect a different administrative designation and postal code. The change clarifies the exact geographic location of the site.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing the previous Revision: v3.5.2. This mirrors a newer version of the study record with likely minor metadata updates.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page now shows a different “Revision” version number for the site (v3.5.2 instead of v3.5.0). No study content appears to change.SummaryDifference0.0%

- Check48 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the locations list. The page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check55 days agoChange DetectedHepatocellular carcinoma keyword added; Genetic and Rare Diseases Information Center added to Resources.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.4.3 has been added to the page footer. Revision: v3.4.2 has been removed.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.